Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients

Clinical and Experimental Rheumatology

Volumn 24, Issue 1, 2006, Pages 51-58

  Saisoong, Supanika ^a   Eiam Ong, Somchai ^a   Hanvivatvong, Orrawadee ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anti dsDNA antibodies; Antinucleosome antibodies; C3; C4; SLE; SLEDAI

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; NUCLEOSOME ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; COMPLEMENT C3; COMPLEMENT C4; DNA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEOSOMES; SEVERITY OF ILLNESS INDEX;

EID: 33645084540     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. HAHN BH: Antibodies to DNA. N Engl J Med 1998; 338: 1359-68.
2. ISENBERG D: Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus? Lupus 2004; 13: 881-5.
3. NOSSENT HC, REKVIG OP: Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal? Arthritis Res Ther 2005; 7: 85-7.
4. RUMORE PM, STEINMAN CR: Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86: 69-74.
5. PISETSKY DS: Systemic lupus erythematosus. Curr Opin Immunol 1991; 3: 917-23.
6. STOLLAR BD: The origin and pathogenic role of anti-DNA autoantibodies. Curr Opin Immunol 1989; 2: 607-12.
7. MADAIO MP, HODDER S, SCHWARTZ RS, STOLLAR BD: Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 1984; 132: 872-6.
8. TAX WJM, KRAMERS C, Van BRUGGEN MCJ, BERDEN JHM: Apoptosis,nucleosomes, and SLE nephritis. Kidney Int 1995; 48: 666-73.
9. MONESTIER M: Autoantibodies to nucleosomes and histone-DNA complexes. Methods 1997; 11: 36-43.
10. AMOURA Z, CHABRE H, BACH JF, KOUTOUZOV S: Antinucleosome antibodies and systemic lupus erythematosus. Adv Nephrol Necker Hosp 1997; 26: 303-16.
11. AMOURA Z, CHABRE H, KOUTOUZOV S et al.: Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 1684-8.
12. BRUNS A, BLASS S, HAUSDORF G, BURMESTER GR, HIEPE F: Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2307-15.
13. WALLACE DJ, LIN HC, SHEN GQ, PETER JB: Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum 1994; 37: 1795-7.
14. CHABRE H, AMOURA Z, PIETTE JC, GODEAU P, BACH JF, KOUTOUZOV S: Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995; 38: 1485-91.
15. AMOURA Z, KOUTOUZOV S, CHABRE H et al.: Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 76-84.
16. AMOURA Z, PIETTE JC, BACH JF, KOUTOUZOV S: The key role of nucleosomes in lupus. Arthritis Rheum 1999; 42: 833-43.
17. MIN DJ, KIM SJ, PARK SH et al.: Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 2002; 20: 13-8.
18. AMOURA Z, CACOUB P, CHABRE H et al.: Prevalence of anti-nucleosome autoantibodies in connective tissue diseases (abstract). Arthritis Rheum 1997; 40 (Suppl. 9): S85.
19. AMOURA Z, PIETTE JC, CHABRE H et al.: Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome anti-body titers and absence of clear association with disease activity. Arthritis Rheum 1997; 40: 2217-25.
20. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
21. BURLINGAME RW, BOEY ML, STARKEBAUM G, RUBIN RL: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 184-92.
22. BURLINGAME RW, RUBIN RL, BALDERAS RS, THEOFILOPOULOS AN: Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 1993; 91: 1687-96.
23. SWAAK AJ, GROENWOLD L BRONSVELD W: Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 359-66.
24. LEE CH, SUH CH, LEE J, KIM YT, LEE SK: The effects of anti-idiotypic antibody on anti-body production and apoptosis of anti-dsDNA antibody producing cells. Clin Exp Rheumatol 2003; 21: 291-300.
25. TOUBI ERI, ROZENBAUM M, KESSEL A, GOLAN TD: The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients. Lupus 2000; 9: 92-5.
26. BOOTSMA H, SPRONK P, DERKSEN R et al.: Prevention of relapse in systemic lupus erythematosus. Lancet; 1995: 1595-9.
27. BORG EJT, HORST G, HUMMEL EJ, LIMBURG PC, KALLENBERG CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: A long-term, propective study. Arthritis Rheum 1990; 33: 634-43.
28. SINICO RA, BOLLINI B, SABADINI E, DI TOMA L, RADICE A: The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J Nephrol 2002; 15 (Suppl. 6): 20-7.
29. SCHUR P, SANDSON J: Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1968; 278: 533-8.